07:26 AM EST, 12/06/2024 (MT Newswires) -- Beam Therapeutics ( BEAM ) said Friday it has appointed Sravan Emany as chief financial officer, succeeding Terry-Ann Burrell who left the company in August.
Emany's term becomes effective Dec. 19.
Emany was previously CFO and chief operating officer of Ironwood Pharmaceuticals.